Zavicefta | Indications/Uses

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Warnings Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Thai FDA Category Presentation/Packing

The information highlighted (if any) are the most recent updates for this brand.

Full Prescribing Info

Indications/Uses

Zavicefta is indicated in adults and paediatric patients aged 3 months and older for the treatment of the following infections (see Precautions and PHARMACOLOGY: Pharmacodynamics under Actions): Complicated intra-abdominal infection (cIAI); Complicated urinary tract infection (cUTI), including pyelonephritis; Hospital-acquired pneumonia (HAP), including ventilator associated pneumonia (VAP).
Treatment of adult patients with bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed as previously mentioned.
Zavicefta is also indicated for the treatment of infections due to aerobic Gram-negative organisms in adults and paediatric patients aged 3 months and older with limited treatment options (see Dosage & Administration, Precautions and PHARMACOLOGY: Pharmacodynamics under Actions).
Consideration should be given to official guidance on the appropriate use of antibacterial agents.

Zavicefta Indications/Uses

ceftazidime + avibactam

Manufacturer:

Pfizer

Distributor:

Zuellig Pharma